Latest filing published 16 Jan 2026 for Egetis Therapeutics AB (publ), €63k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mats Blom: trading record in brief
All filings by Mats Blom on record concern Egetis Therapeutics AB (publ). We count 5 filings; the first trade dates from 17 May 2022 and the latest from 14 January 2026.
On the market, this insider has only ever bought: 4 purchases, €247k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 1 purchase and no sales on the market.
In size, the median ticket on the buying side is €74k. Across 4 purchases, this insider has always bought alone, with no colleague buying within 30 days.
Most recently, on 16 January 2026, the filings show an open-market purchase worth €63k in Egetis Therapeutics AB (publ). Between a trade and the moment it shows up on Finansinspektionen, the median delay is 2 days. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Mats Blom
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 150,000 shares@ SEK 4.4825.3% of flowAktieISIN SE0003815604FI:csv-0978a9417f18629acd6aCanonical exit: 14 Apr 2026 (T+90)
- 180,000 shares@ SEK 5.2434.6% of flowAktieISIN SE0003815604FI:csv-59d77877bb437f7d82b3Canonical exit: 23 Feb 2026 (T+90)
- 35,000 shares@ SEK 4.295.5% of flowAktieISIN SE0003815604FI:csv-3c041bb7cd2283694269Canonical exit: 24 Feb 2026 (T+90)
- 200,000 shares@ SEK 4.95826.6% of flowAktieISIN SE0003815604FI:csv-f0ccb48c773320d5e92bCanonical exit: 29 Aug 2023 (T+90)
- 677,250 shares@ SEK 3.6573.4% of flowBTA (betald tecknad aktie)ISIN SE0017770027FI:csv-e711ded14d990ad6c534
5 of 5 declarations